IRIS Accounts Production v24.1.0.578 12032548 Board of Directors 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure120325482022-06-30120325482023-06-30120325482022-07-012023-06-30120325482021-06-30120325482021-07-012022-06-30120325482022-06-3012032548ns16:EnglandWales2022-07-012023-06-3012032548ns15:PoundSterling2022-07-012023-06-3012032548ns11:Director12022-07-012023-06-3012032548ns11:PrivateLimitedCompanyLtd2022-07-012023-06-3012032548ns11:SmallEntities2022-07-012023-06-3012032548ns11:AuditExempt-NoAccountantsReport2022-07-012023-06-3012032548ns11:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3012032548ns11:SmallCompaniesRegimeForAccounts2022-07-012023-06-3012032548ns11:FullAccounts2022-07-012023-06-3012032548ns11:OrdinaryShareClass12022-07-012023-06-3012032548ns11:OrdinaryShareClass22022-07-012023-06-3012032548ns6:CurrentFinancialInstruments2023-06-3012032548ns6:CurrentFinancialInstruments2022-06-3012032548ns6:ShareCapital2023-06-3012032548ns6:ShareCapital2022-06-3012032548ns6:RetainedEarningsAccumulatedLosses2023-06-3012032548ns6:RetainedEarningsAccumulatedLosses2022-06-3012032548ns11:RegisteredOffice2022-07-012023-06-3012032548ns6:ComputerEquipment2022-06-3012032548ns6:ComputerEquipment2022-07-012023-06-3012032548ns6:ComputerEquipment2023-06-3012032548ns6:ComputerEquipment2022-06-3012032548ns11:OrdinaryShareClass12023-06-3012032548ns11:OrdinaryShareClass22023-06-3012032548ns11:Director22022-07-012023-06-30120325482ns11:Director22022-06-30120325482ns11:Director22021-06-30120325482ns11:Director22022-07-012023-06-30120325482ns11:Director22021-07-012022-06-30120325482ns11:Director22023-06-30120325482ns11:Director22022-06-30
REGISTERED NUMBER: 12032548 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th June 2023

for

KVMS Medical Ltd

KVMS Medical Ltd (Registered number: 12032548)






Contents of the Financial Statements
for the Year Ended 30th June 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


KVMS Medical Ltd (Registered number: 12032548)

Balance Sheet
30th June 2023

30.6.23 30.6.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 73 160

CURRENT ASSETS
Debtors 5 7,131 6,084
Cash at bank 130,411 93,734
137,542 99,818
CREDITORS
Amounts falling due within one year 6 19,496 18,178
NET CURRENT ASSETS 118,046 81,640
TOTAL ASSETS LESS CURRENT
LIABILITIES

118,119

81,800

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 118,019 81,700
SHAREHOLDERS' FUNDS 118,119 81,800

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16th April 2024 and were signed on its behalf by:





Dr M J Stechman - Director


KVMS Medical Ltd (Registered number: 12032548)

Notes to the Financial Statements
for the Year Ended 30th June 2023

1. COMPANY INFORMATION

KVMS Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12032548

Registered office: First Floor
49 Peter Street
Manchester
M2 3NG

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its
estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation,
net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values
over their useful lives on the following basis:

Computer Equipments - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale
proceeds and the carrying value of the asset and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


KVMS Medical Ltd (Registered number: 12032548)

Notes to the Financial Statements - continued
for the Year Ended 30th June 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1st July 2022
and 30th June 2023 349
DEPRECIATION
At 1st July 2022 189
Charge for year 87
At 30th June 2023 276
NET BOOK VALUE
At 30th June 2023 73
At 30th June 2022 160

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Trade debtors 7,131 6,084

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Tax 10,006 10,982
Directors' current accounts 8,519 6,207
Accrued expenses 971 989
19,496 18,178

KVMS Medical Ltd (Registered number: 12032548)

Notes to the Financial Statements - continued
for the Year Ended 30th June 2023

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.23 30.6.22
value: £    £   
50 Ordinary A 1 50 50
50 Ordinary B 1 50 50
100 100

Ordinary A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

Ordinary B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in terms of dividend and capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th June 2023 and 30th June 2022:

30.6.23 30.6.22
£    £   
Ms K Vardulaki
Balance outstanding at start of year (6,207 ) (5,895 )
Amounts advanced 4,000 -
Amounts repaid (6,312 ) (312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (8,519 ) (6,207 )

The loan is payable on demand and no interest was charged during the year.

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr M J Stechman.